Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹113Cr
Rev Gr TTM
Revenue Growth TTM
-4.53%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MODAIRY
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 61.4 | 89.8 | 90.6 | 102.7 | 20.9 | 13.6 | -8.4 | -11.2 | -6.9 | -17.1 | 11.0 | -1.4 |
| 76 | 79 | 77 | 94 | 90 | 89 | 70 | 86 | 89 | 75 | 79 | 85 |
Operating Profit Operating ProfitCr |
| 5.7 | 4.8 | 4.9 | 6.2 | 7.6 | 5.3 | 5.5 | 3.5 | 1.9 | 3.9 | 3.3 | 2.7 |
Other Income Other IncomeCr | 0 | 0 | 19 | 0 | 0 | 0 | 0 | 56 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 3 | 2 | 21 | 5 | 6 | 4 | 3 | 58 | 1 | 2 | 2 | 2 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 4.4 | -23.8 | 403.3 | 70.6 | 142.0 | 91.1 | -84.4 | 1,181.6 | 181.7 | -57.3 | -49.1 | -97.9 |
| 3.2 | 2.4 | 26.5 | 4.5 | 6.5 | 4.1 | 4.5 | 65.3 | 19.6 | 2.1 | 2.1 | 1.4 |
| 1.1 | 0.9 | 9.2 | 1.9 | 2.7 | 1.6 | 1.4 | 24.8 | 7.5 | 0.6 | 0.6 | 0.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| -2.0 | -20.5 | -8.0 | 2.1 | 20.1 | 36.6 | -20.3 | -60.6 | -9.6 | 66.2 | -3.7 | -2.7 |
| 629 | 499 | 463 | 480 | 549 | 757 | 600 | 231 | 201 | 340 | 334 | 329 |
Operating Profit Operating ProfitCr |
| -0.6 | -0.4 | -1.3 | -2.9 | 2.0 | 1.1 | 1.7 | 4.1 | 7.7 | 6.0 | 4.0 | 2.9 |
Other Income Other IncomeCr | 1 | 0 | 14 | 0 | 0 | 0 | -22 | 2 | 1 | 20 | 57 | 1 |
Interest Expense Interest ExpenseCr | 17 | 18 | 17 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 2 | 1 |
Depreciation DepreciationCr | 5 | 5 | 5 | 5 | 5 | 6 | 22 | 6 | 3 | 3 | 3 | 3 |
| -24 | -24 | -13 | -19 | 6 | 3 | -35 | 5 | 12 | 34 | 66 | 6 |
| -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17 | -16 |
|
| -335.6 | -8.9 | 44.9 | -39.0 | 132.6 | -42.4 | -1,095.9 | 114.3 | 145.5 | 181.6 | 142.4 | -73.0 |
| -3.6 | -4.9 | -2.9 | -4.0 | 1.1 | 0.5 | -5.7 | 2.1 | 5.6 | 9.5 | 23.8 | 6.6 |
| -9.5 | -10.4 | -4.9 | -8.0 | 2.6 | 1.5 | -14.9 | 2.1 | 5.2 | 14.7 | 35.5 | 9.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 26 | 26 |
| -57 | -81 | -95 | -111 | -105 | -102 | -136 | -131 | -119 | -85 | 7 | 18 |
Current Liabilities Current LiabilitiesCr | 135 | 147 | 114 | 203 | 216 | 208 | 186 | 169 | 180 | 142 | 68 | 68 |
Non Current Liabilities Non Current LiabilitiesCr | 98 | 85 | 109 | 2 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 116 | 93 | 74 | 31 | 51 | 53 | 38 | 28 | 51 | 54 | 63 | 64 |
Non Current Assets Non Current AssetsCr | 83 | 81 | 77 | 86 | 84 | 78 | 36 | 33 | 34 | 36 | 54 | 56 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 17 | 30 | -10 | 16 | 4 | 6 | 7 | 17 | 15 | 47 | 20 |
Investing Cash Flow Investing Cash FlowCr | -2 | -2 | 0 | -3 | -4 | -5 | -3 | -2 | -3 | -5 | -4 |
Financing Cash Flow Financing Cash FlowCr | -16 | -22 | 6 | -11 | 0 | -2 | -3 | -9 | -19 | -41 | -10 |
|
Free Cash Flow Free Cash FlowCr | 15 | 28 | -11 | 13 | -1 | 1 | 3 | 15 | 12 | 43 | 17 |
| -76.3 | -124.4 | 78.2 | -85.7 | 59.5 | 179.4 | -19.3 | 338.9 | 124.4 | 138.6 | 24.3 |
CFO To EBITDA CFO To EBITDA% | -489.6 | -1,515.0 | 176.4 | -117.0 | 32.0 | 72.0 | 65.8 | 170.8 | 90.4 | 219.3 | 144.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 27 | 23 | 29 | 16 | 12 | 5 | 23 | 18 | 44 | 69 | 136 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | 1.3 | 0.0 | 3.6 | 3.6 | 2.0 | 1.6 |
Price To Sales Price To Sales | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.4 |
Price To Book Price To Book | -0.8 | -0.4 | -0.4 | -0.2 | -0.1 | -0.1 | -0.2 | -0.2 | -0.5 | -1.1 | 4.2 |
| -55.4 | -86.2 | -34.5 | -1.1 | 0.9 | 0.5 | 2.2 | 1.1 | 2.6 | 3.5 | 9.7 |
Profitability Ratios Profitability Ratios |
| 7.0 | 7.3 | 6.6 | 5.3 | 9.6 | 6.7 | 8.7 | 23.3 | 30.4 | 22.5 | 20.6 |
| -0.6 | -0.4 | -1.3 | -2.9 | 2.0 | 1.1 | 1.7 | 4.1 | 7.7 | 6.0 | 4.0 |
| -3.6 | -4.9 | -2.9 | -4.0 | 1.1 | 0.5 | -5.7 | 2.1 | 5.6 | 9.5 | 23.8 |
| -5.1 | -6.9 | 3.1 | 21.0 | -7.7 | -4.6 | 30.7 | -4.7 | -15.4 | -70.7 | 170.0 |
| 66.1 | 41.8 | 18.8 | 21.1 | -7.4 | -4.5 | 30.7 | -4.6 | -12.7 | -55.5 | 255.4 |
| -11.2 | -13.9 | -8.8 | -15.9 | 4.5 | 2.7 | -46.6 | 8.0 | 14.3 | 38.1 | 71.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Modern Dairies Limited (**MDL**) is a prominent Indian dairy processor headquartered in **Chandigarh** with a centralized, integrated manufacturing facility in **Karnal, Haryana**. Operating as a single primary reportable segment under **Ind AS 108**, the company specializes in the procurement and processing of raw milk into a diverse range of fresh dairy products, cultured health foods, and specialized nutritional ingredients.
The company serves a dual market: providing high-quality consumer goods to the domestic market and acting as a strategic B2B supplier of specialized ingredients to leading multinational food and pharmaceutical companies operating in India.
---
### Specialized Product Portfolio & Market Positioning
MDL has transitioned from a traditional milk processor to a value-added dairy player, focusing on **protein-rich** and **fortified** options to meet evolving consumer health trends.
* **Fresh & Value-Added Dairy:** Liquid Milk (including fortified variants), Pure Ghee, Butter, Paneer, and traditional Indian dairy products like Dahi, Lassi, and Chachh.
* **Milk Powders:** Skimmed Milk Powder (**SMP**), Whole Milk Powder (**WMP**), and Dairy Whitener.
* **Nutritional & Pharma Ingredients:**
* **Casein** and **Whey Protein Concentrate (WPC)** for the health and fitness industry.
* **Pharma Grade Lactose**, catering to the stringent requirements of the pharmaceutical sector.
* **Health & Probiotics:** Flavored Yoghurts and Probiotic drinks designed for health-conscious consumers.
---
### Manufacturing Excellence & Quality Benchmarks
The company’s operations are concentrated at its facility at **136 KM, G.T. Road, Karnal**, which is strategically located in a high-milk-yield belt. As of March 31, 2025, the facility is supported by a workforce of **453 persons**.
MDL maintains a rigorous quality framework to sustain its status as an approved supplier to global multinationals:
| Certification / Approval | Issuing Authority / Standard |
|:---|:---|
| **Quality Management** | **ISO 9001**, **FSSC 22000** (Certified by DNVGL Netherlands) |
| **Environmental Management** | **ISO 14001** |
| **Pharma Grade Lactose** | **WHO-GMP** (Good Manufacturing Practices) |
| **Export Compliance** | **USFDA**, **Export Inspection Agency**, **APEDA**, **HALAL** |
**Operational Efficiency Metrics:**
The company monitors utility consumption per **1,000 kgs** of milk processed to drive cost-efficiency:
* **Electricity Consumption:** Ranges between **80.25 - 86.27 kwh**.
* **Fuel Quantity:** Ranges between **67.35 - 82.21 kgs**.
---
### Capital Restructuring & Promoter Equity Infusion
To strengthen its balance sheet and fund long-term working capital, MDL is executing a significant capital raising plan through the issuance of convertible securities to its promoter group.
* **Preferential Allotment:** The company is raising **Rs. 43 Crore** via **86,00,000 Convertible Warrants** at an issue price of **Rs. 50** (including a **Rs. 40 premium**).
* **Warrant Conversion Progress:** As of February 2026, **39,00,000 warrants** have been converted into equity, realizing **Rs. 14.625 Crore** in capital.
* **Authorized Capital:** In September 2024, the company increased its authorized share capital from **Rs. 30 Crore** to **Rs. 35 Crore** to facilitate this expansion.
* **Promoter Commitment:** Despite the infusion, **45.69%** of the total share capital (**1,06,54,779 shares**) remains pledged to lenders as part of historical debt arrangements.
---
### Financial Performance & Debt Resolution
While MDL has shown strong revenue growth over a three-year horizon, recent performance has been tempered by raw material price volatility.
**Financial Summary (₹ in Lacs):**
| Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | **3,48,92** | **3,62,04** | **2,18,76** |
| **Operating Profit** | **14,77** | **22,19** | **18,00** |
| **Dividend** | **Nil** | **Nil** | **Nil** |
**Debt Resolution Milestones:**
The company has successfully navigated a period of financial stress through **One-Time Settlements (OTS)**:
* **Punjab National Bank (PNB):** Settled for **Rs. 45.94 Crore** in November 2024; all dues are now fully cleared.
* **Canara Bank:** Settled for **Rs. 9.95 Crore** in January 2025.
* **Edelweiss ARC:** Debt restructured and fully paid off by August 2023, resulting in an exceptional gain of **Rs. 27.95 Crore** from debt write-offs.
---
### Strategic Partnerships & Governance
MDL leverages related party synergies to optimize its supply chain and market reach:
* **Modern Dairyfarms Limited:** A strategic sourcing arrangement with a shareholder-approved transaction limit of **Rs. 180 Crore** per annum.
* **Nabha Commerce Private Limited:** A material agreement for product sales/purchases capped at **Rs. 60 Crore** per year through **2030**.
* **Board Continuity:** **Dr. Meena Sharma** was re-appointed as an Independent Director until **2027**, ensuring stability following the demise of a board member in early 2025.
---
### Critical Risk Factors & Contingencies
Investors should note several significant legal and regulatory headwinds:
**1. Milk Cess Litigation (High Exposure):**
The company is contesting a levy under the **Haryana Murrah Buffalo and other Animal Breed Act, 2001**.
* The Government of Haryana has demanded **Rs. 544.31 Crore** (including interest).
* The matter is currently pending as a **Special Leave Petition (SLP)** in the **Supreme Court**.
* MDL has provided **Rs. 21.74 Crore** in its accounts as a cautionary measure and deposited **Rs. 9.91 Crore** with authorities.
**2. Managerial Remuneration Audit Qualification:**
Auditors have flagged **Rs. 3.57 Crore** in remuneration paid to the Managing and Executive Directors that does not comply with **Section 197 of the Companies Act, 2013**. This remains a "Qualified Opinion" in audit reports pending formal approval or refund.
**3. Margin & Macro Risks:**
* **Raw Milk Volatility:** High procurement prices in **FY25** directly compressed margins.
* **Taxation:** The company has **not recognized deferred tax assets** due to the lack of "virtual certainty" regarding future taxable profits amidst ongoing litigation.
* **Labour Codes:** The impact of the new **2019-2020 Labour Codes** is yet to be fully determined as final rules are awaited.
---
### Future Outlook
The company’s strategy for the upcoming fiscal year rests on **product mix optimization** and **operational deleveraging**. With the completion of major bank settlements and a focus on high-margin **nutritional ingredients**, MDL aims to capitalize on a favorable monsoon forecast and stabilized milk availability to restore profitability margins.